BNP Paribas Financial Markets
EXOZ

BNP Paribas Financial Markets’s eXoZymes Inc EXOZ Stock Holding History

BNP Paribas Financial Markets’s Portfolio EXOZ Stock Details EXOZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,113
Closed -$34.9K – 5623
2024
Q4 		$34.9K Buy
+2,113
New +$31.2K ﹤0.01% 4560

Other funds holding EXOZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets's EXOZ Position: Q1 2025 in Review

BNP Paribas Financial Markets sold out of eXoZymes Inc (EXOZ) in Q1 2025, closing a stake of 2,113 shares — an estimated $34.9K sold.

BNP Paribas Financial Markets first reported a position in EXOZ in Q4 2024 and held it in 1 quarter. The position peaked at $34.9K in Q4 2024. 6 funds tracked by Wall St. Rank hold EXOZ as of Q1 2025.

  • BNP Paribas Financial Markets reported no remaining eXoZymes Inc position as of Q1 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 2,113 eXoZymes Inc shares in Q1 2025, an estimated $34.9K.
  • BNP Paribas Financial Markets first reported a position in eXoZymes Inc in Q4 2024 and held it in 1 quarter.
  • BNP Paribas Financial Markets's eXoZymes Inc position peaked at $34.9K in Q4 2024.
  • 6 funds tracked by Wall St. Rank held eXoZymes Inc as of Q1 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2025, filed 14 May 2025.